Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
BMBiomerica, Inc. logo

Biomerica, Inc. (BMRA)

NASDAQ Capital Market · Currency in USD
$1.68 ▲ +0.00 (+0.00%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.67 ▼ -0.01 (-0.60%)
After hours: Oct 23, 6:33 PM ET

Summary

Previous Close
$1.68
Open
$1.68
Day's Range
$1.65 – $1.72
52 Week Range
$1.45 – $3.09
Volume
12,005
Avg. Volume
54,043
Market Cap
$7.73M
Beta (5Y Monthly)
0.31
PE Ratio (TTM)
--
EPS (TTM)
-$1.52
Earnings Date
Jan 8, 2027
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Biomerica, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
50
CEO
Zackary S. Irani

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste.

Earnings

Next report: Fri, Jan 8, 2027
EPS estimate -$1.20 · Revenue est. $3.63M
DateEst.Actual
Oct 15, 2026-$1.20-$0.37Beat
Aug 31, 2026-$1.20-$0.38Beat
Apr 13, 2026-$1.20-$0.44Beat
Jan 14, 2026$0.32-$0.45Miss
Oct 14, 2025$0.32$0.00Miss
Aug 29, 2025$0.16-$0.16Miss

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on BMRA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.